- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
While interest rates probably aren't going anywhere, some expect a change in tone.
The cable company's fourth-quarter loss follows a massive pretax gain in the year-ago period.
Mergers and acquisitions volume is on pace with 2000's merger mania.
Profits surge on a big gain in newspaper income.
A company meets estimates and points to increases in premiums and annuity deposits.
Investors aren't impressed with the company's prospects.
Five new issues debut and perform well despite the market's recent slump.
Cheaper stocks outperformed Wednesday as investors looked to rotate.
The defense contractor sticks to 2004 guidance after flat fourth-quarter earnings.